open evidenceA tool that doctors and nurses have compared to ChatGPT for medicine is planning to announce a $200 million raise at a $6 billion valuation, New York Times report,
The fresh funding comes three months after the startup raised $210 million at a valuation of $3.5 billion, evidence of intense investor interest in industry-specific AI applications.
Trained on medical journals from JAMA and the New England Journal of Medicine, the OpenEvidence platform helps users quickly get answers to existing medical knowledge to help treat patients. Verified medical professionals can access OpenEvidence’s tools for free, which is supported by advertising.
OpenEvidence has grown rapidly since its founding in 2022. Its number of clinical consultations per month has almost doubled to 15 million since July, according to the Times.
The round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Kraft.
TechCrunch has contacted OpenEvidence for comment.
techcrunch event
san francisco
,
October 27-29, 2025
